Diabetes Trials

Available Diabetes Health Trials:

• (175-24) A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Pivotal Study to Assess the Efficacy of Revita® Duodenal Mucosal Resurfacing (DMR) on Body Weight Maintenance in Participants with Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide Obesity Pharmacotherapy (REMAIN-1)

• (192-24) A Single-arm Trial With an Innovative Automated Insulin Delivery System for Type 2 Diabetes (“twiist-T2D”)

• (243-24) A Study to Investigate Efficacy and Long-Term Safety of Tirzepatide Compared with Placebo in Adult Participants with Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-2)

Your participation in any trial is entirely voluntary. You may decide to withdraw at any time without losing the benefits of your standard medical care. To learn more about available clinical trials, please contact us at 949-764-4577 or clinicalresearch@hoag.org.